Navigation path

Pharmaceuticals - Community Register


Community register of orphan medicinal products


Product information

Recombinant human arylsulfatase A

EU orphan designation number: EU/3/10/813   
Active ingredient: Recombinant human arylsulfatase A
Indication: Treatment of metachromatic leukodystrophy
Sponsor: Shire Pharmaceuticals Ireland Limited
Block 2-3 Miesian Plaza, 50-58 Baggot Street Lower, Dublin 2, Ireland

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
2/12/2010 Orphan designation EMA/OD/070/10 (2010)8598 of 26/11/2010
6/11/2017 Change of name and/or address of sponsor